Abstract

Acid–base disorders are common in critically ill patients. Metabolic acid–base disorders are particularly common in patients who require acute renal replacement therapy. In these patients, metabolic acidosis is common and multifactorial in origin. Analysis of acid–base status using the Stewart–Figge methodology shows that these patients have greater acidemia despite the presence of hypoalbuminemic alkalosis. This acidemia is mostly secondary to hyperphosphatemia, hyperlactatemia, and the accumulation of unmeasured anions. Once continuous hemofiltration is started, profound changes in acid–base status are rapidly achieved. They result in the progressive resolution of acidemia and acidosis, with a lowering of concentrations of phosphate and unmeasured anions. However, if lactate-based dialysate or replacement fluid are used, then in some patients hyperlactatemia results, which decreases the strong ion difference and induces an iatrogenic metabolic acidosis. Such hyperlactatemic acidosis is particularly marked in lactate-intolerant patients (shock with lactic acidosis and/or liver disease) and is particularly strong if high-volume hemofiltration is performed with the associated high lactate load, which overcomes the patient's metabolic capacity for lactate. In such patients, bicarbonate dialysis seems desirable. In all patients, once hemofiltration is established, it becomes the dominant force in controlling metabolic acid–base status and, in stable patients, it typically results in a degree of metabolic alkalosis. The nature and extent of these acid–base changes is governed by the intensity of plasma water exchange/dialysis and by the 'buffer' content of the replacement fluid/dialysate, with different effects depending on whether lactate, acetate, citrate, or bicarbonate is used. These effects can be achieved in any patient irrespective of whether they have acute renal failure, because of the overwhelming effect of plasma water exchange on nonvolatile acid balance. Critical care physicians must understand the nature, origin, and magnitude of alterations in acid–base status seen with acute renal failure and during continuous hemofiltration if they wish to provide their patients with safe and effective care.

Highlights

  • Acute renal failure (ARF) in the critically ill is still associated with a poor prognosis [1,2]

  • In the present review we explore the acid–base disorders seen in ARF, the effect of renal replacement therapy (RRT) and its modalities on acid–base disorders, the effect of replacement fluid on acid–base balance, and the effect of high-volume hemofiltration (HVHF) on acid–base balance

  • The overwhelming superiority of continuous RRT in terms of control of acidosis was recently established in comparison with peritoneal dialysis, with all patients randomized to continuous venovenous hemofiltration (CVVH) achieving correction of acidosis by 50 hours of treatment, compared with only 15% of those treated by peritoneal dialysis (P < 0.001) [12]

Read more

Summary

Introduction

Acute renal failure (ARF) in the critically ill is still associated with a poor prognosis [1,2]. This change was associated with a decreased SIG, and decreased phosphate and chloride concentrations This correction was so powerful and dominant that, after 3 days of CVVH, patients developed alkalemia secondary to metabolic alkalosis (bicarbonate 29.8 mmol/l, base excess 6.7 mmol/l; Fig. 1). This alkalemia appeared due to a further decrease in SIG and a further decrease in serum phosphate concentration in the setting of persistent hypoalbuminemia. Hyperlactatemia has been reported with lactate-buffered fluids in critically ill ARF patients treated with intermittent hemofiltration and a lactate load of 190–210 mmol/hour [16] Such hyperlactatemia might induce a metabolic acidosis.

Conclusion
Stewart PA
Findings
10. Niwa T
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call